Key Takeaways From Molina Healthcare Analyst Ratings
Molina Healthcare Analyst Ratings
Truist Securities Maintains Buy on Molina Healthcare, Lowers Price Target to $400
Analysts Conflicted on These Healthcare Names: Daiichi Sankyo Company (OtherDSKYF), Inovio Pharmaceuticals (INO) and Molina Healthcare (MOH)
Molina Healthcare Analyst Ratings
JPMorgan Adjusts Price Target on Molina Healthcare to $395 From $420
Stephens Adjusts Price Target on Molina Healthcare to $320 From $355
Barclays Adjusts Price Target on Molina Healthcare to $359 From $430, Maintains Equalweight Rating
Molina Healthcare Analyst Ratings
JPMorgan Adjusts Price Target on Molina Healthcare to $420 From $435
Wells Fargo Reaffirms Their Hold Rating on Molina Healthcare (MOH)
Molina Healthcare Analyst Ratings
Baird Initiates Molina Healthcare With Outperform Rating, $405 Price Target
Molina Healthcare Analyst Ratings
TD Cowen Adjusts Price Target on Molina Healthcare to $412 From $453, Keeps Buy Rating
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Cytokinetics (CYTK)
Molina Healthcare Analyst Ratings
Wells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $375
Goldman Sachs Adjusts Molina Healthcare Price Target to $442 From $463
Molina Healthcare Analyst Ratings